Cibc Private Wealth Group, LLC Xenon Pharmaceuticals Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 39 shares of XENE stock, worth $1,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$1,198% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$176 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$141 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$116 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$102 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$94.9 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.91B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...